VAERS Datenanalyse und Statistik
VAERS DatenanalyseSuche nach Chargen, Symptomen, Reports und Statistiken
Zurueck zur Suche

Reporte zur Charge U029144

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

7Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
CA 2 NY 2 ND 1 LA 1 GA 1

VAERS 2575140

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge U029144

gering
Staat
ND
Alter
1,3
Geschlecht
F
Eingang
03.02.2023
Impfdatum
01.02.2023
Beginn
01.02.2023
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Incorrect product formulation administered No adverse event

Symptomtext

Patient received Pfizer's <5 Bivalent COVID vaccine as the second dose instead of the <5 Monovalent. No adverse effects noted.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect product formulation administered
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None.
Vorgeschichte
None.
Andere Medikamente
None
Allergien
None known.
Vorherige Impfungen
-

VAERS 2547946

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge U029144

gering
Staat
CA
Alter
-
Geschlecht
U
Eingang
02.01.2023
Impfdatum
02.12.2022
Beginn
02.12.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no additional AEs; it was reported multiple temperature excursion 16-NOV-2022 and 09-DEC-2022 and were administered PEDVAXHIB, ROTATEQ and VAQTA; This spontaneous report was received from a medical assistant and refers to an unspecified group of patients of unknown age and gender. Their medical history, concurrent conditions and concomitant therapies were not reported. On 16-NOV-2022 and 09-DEC-2022, the patients were vaccinated with Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAXHIB) lot number: U029144 and expiration date: 31-MAR-2024; with Hepatitis A Vaccine, Inactivated (VAQTA) lot number: W015191 and expiration date: 27-OCT-2023; and with Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) lot number: U038854 and expiration date: 20-APR-2023. The vaccines were administered only once for prophylaxis, but dosage regimens, route of administrations and anatomical locations were not reported. It was reported that the vaccines were administered after multiple temperature excursions (product storage error). Temperature was above 47 Fahrenheit (F) degree (50.0 F) for 0 hours 12 minutes and 0 seconds on 16-NOV-2022 and above 47 F (47.6F) for 0 hours 15 minutes and 0 seconds. Time frame was total 27 minutes. Additionally, no previous temperature excursion was reported. No other adverse event was reported (no adverse event). Follow-up information was received from the medical assistant on 28-DEC-2022. This report refers to a 15 month old patient who was vaccinated on 02-DEC-2022 with Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAXHIB) lot number: U029144 and expiration date: 31-MAR-2024, intramuscular (IM). The primary thermometer displayed out of range temperature for less than 15 minutes. The back-up thermometer did not display max. that was out of range. Log was ran and the temperatures were within range. The primary thermometer was re-calibrated. Patients' identifiers were missing in the previous report but have now been provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2547934

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge U029144

gering
Staat
CA
Alter
-
Geschlecht
U
Eingang
02.01.2023
Impfdatum
30.11.2022
Beginn
30.11.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no additional AEs; it was reported multiple temperature excursion 16-NOV-2022 and 09-DEC-2022 and were administered PEDVAXHIB, ROTATEQ and VAQTA; This spontaneous report was received from a medical assistant and refers to an unspecified group of patients of unknown age and gender. Their medical history, concurrent conditions and concomitant therapies were not reported. On 16-NOV-2022 and 09-DEC-2022, the patients were vaccinated with Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAXHIB) lot number: U029144 and expiration date: 31-MAR-2024; with Hepatitis A Vaccine, Inactivated (VAQTA) lot number: W015191 and expiration date: 27-OCT-2023; and with Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) lot number: U038854 and expiration date: 20-APR-2023. The vaccines were administered only once for prophylaxis, but dosage regimens, route of administrations and anatomical locations were not reported. It was reported that the vaccines were administered after multiple temperature excursions (product storage error). Temperature was above 47 Fahrenheit (F) degree (50.0 F) for 0 hours 12 minutes and 0 seconds on 16-NOV-2022 and above 47 F (47.6F) for 0 hours 15 minutes and 0 seconds. Time frame was total 27 minutes. Additionally, no previous temperature excursion was reported. No other adverse event was reported (no adverse event). Follow-up information was received from the medical assistant on 28-DEC-2022. This report refers to a 15 month old patient who was vaccinated on 30-NOV-2022 with Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAXHIB) lot number: U029144 and expiration date: 31-MAR-2024, intramuscular (IM). The primary thermometer displayed out of range temperature for less than 15 minutes. The back-up thermometer did not display max. that was out of range. Log was ran and the temperatures were within range. The primary thermometer was re-calibrated. Patients' identifiers were missing in the previous report but have now been provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2479169

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge U029144

gering
Staat
LA
Alter
-
Geschlecht
U
Eingang
15.10.2022
Impfdatum
05.10.2022
Beginn
05.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE reported; potential temperautre excursion/but could not confirm if a temperautre excursion had occurred prior to the administration; This spontaneous report was received from a licensed practical nurse and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history, concomitant therapies, drug reactions and allergies were not provided. The nurse reported that her data logger did not record temperatures for about a week. Haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) was "assumed to be in normal storage range", but could not confirm if a temperature excursion had occurred prior to the administration. On 05-OCT-2022, the patient was vaccinated with a dose of improperly stored haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) intramuscular injection, 0.5ml, lot #U029144, expiration date: 31-MAR-2024, (strength, site and route of vaccination were not provided) for prophylaxis. No additional adverse event (AE) was reported (no adverse event). The temperature excursion for haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) was unknown. It was unknown if the previous temperature excursion occurred.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2415565

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge U029144

gering
Staat
NY
Alter
-
Geschlecht
U
Eingang
19.08.2022
Impfdatum
12.08.2022
Beginn
12.08.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered No adverse event

Symptomtext

Patient did not experience any side effects. No additional AE/No PQC.; a patient accidentally received a 4th dose of PEDVAXHIB; This spontaneous report as received from a registered nurse referring to a patient of unknown age and gender. Information about pertinent medical history, drug reaction/allergy and concomitant medication was not provided. On 12-AUG-2022, the patient accidentally received a 4th dose of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) (0.5 mL/once, lot # U029144, expiration date 31-MAR-2024; strength, route of administration and anatomical location were not reported) for prophylaxis (extra dose administered). The patient's 3rd dose was not documented in charts and it was not realized until after the patient had received a 4th dose. The patient did not experience any side effects. No additional adverse event (AE) or product quality complaint (PQC) was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2409968

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge U029144

gering
Staat
NY
Alter
2,0
Geschlecht
M
Eingang
12.08.2022
Impfdatum
12.08.2022
Beginn
12.08.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered

Symptomtext

Patient received extra 4th dose of Hib when it was not needed per manufacturers guidelines, no adverse effect reported, Manufacturer states per CDC, no harm with extra dose and to monitor for side effects per usual.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
-
Vorgeschichte
Preterm infant, Neonatal Anemia, Delayed Milestones Motor Gross, Bronchopulmonary Dysplasia of newborn, Eteral Nutrition via Feeding Tube.
Andere Medikamente
none
Allergien
NKA
Vorherige Impfungen
-

VAERS 2292795

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge u029144

gering
Staat
GA
Alter
1,3
Geschlecht
M
Eingang
24.05.2022
Impfdatum
17.05.2022
Beginn
24.05.2022
Tage bis Beginn
7,0
Dosis
3
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Nodule

Symptomtext

Left thigh with 1 cm nodule, no fever; walking without difficulty

Weitere VAERSDATA-Felder
Praegender Schweregrund
Nodule
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-